About Paclitaxel 260 Mg Injections
Select the incomparable Paclitaxel 260 Mg Injection-our new release designed for adults requiring heroic cancer care. This sought-after antineoplastic, formulated to IP pharmacopoeia standards, boasts a clear, liquid presentation and is housed in a quality glass vial. Personalise patient treatment with physician-guided dosing for optimum benefit. Specifically recommended for breast cancer, every single dose is expertly composed and supplied from India. With a life span of 24 months and a robust packaging type, safety and efficacy are assured with each vial. Prescription required.
Used For & Diverse Applications
Paclitaxel 260 Mg Injection is predominantly used for the treatment of breast cancer and is administered intravenously. This antineoplastic agent is specifically applied in clinical oncology settings, acting directly at the site of cancer through an IV route. Beyond breast cancer, this medicine is being explored for efficacy in other solid tumor management, under professional supervision. Its versatility and effectiveness render it an essential in modern cancer therapy regimens.
Domestic Market Reach & Supply Assurance
Our Paclitaxel 260 Mg Injections serve the main domestic market across India with stock ready for immediate fulfilment. High supply ability ensures that expenditure for urgent shipments is minimized, and samples are available upon request to allow informed decision-making. Each shipment is managed efficiently, supporting healthcare facilities and traders nationwide in maintaining consistent treatment protocols without delay.
FAQ's of Paclitaxel 260 Mg Injections:
Q: How should Paclitaxel 260 Mg Injection be administered?
A: Paclitaxel 260 Mg Injection should be administered intravenously by healthcare professionals as directed by a physician. It is essential to follow strict dosage guidelines and only use as prescribed.
Q: What are the main benefits of using Paclitaxel 260 Mg Injection?
A: The main benefit lies in its heroically effective role as an antineoplastic agent for treating breast cancer, offering sought-after results in slowing or stopping tumor growth in adults.
Q: When should patients start Paclitaxel therapy?
A: Paclitaxel therapy should begin following a confirmed diagnosis of breast cancer and under the supervision and recommendation of a qualified oncologist.
Q: Where is Paclitaxel 260 Mg Injection sourced and manufactured?
A: This injection is sourced and manufactured in India, adhering to the IP pharmacopoeia standard for assured safety, purity, and efficacy.
Q: What is the process for obtaining a sample of Paclitaxel 260 Mg Injection?
A: Healthcare professionals or registered institutions can request a sample by contacting our supply team directly. Samples are available to support informed therapeutic decisions.
Q: What are the storage requirements for Paclitaxel 260 Mg Injection?
A: Store the vial at a controlled room temperature between 20-25C to ensure the stability and effectiveness of the medicine throughout its 24-month life span.